Navigation Links
Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session
Date:3/29/2009

Long-Term Data Demonstrate The OPTIMIZER(R) System to be Safe and Effective

ORLANDO, Fla., March 29 /PRNewswire/ -- Impulse Dynamics (U.S.A.) Inc. announced today findings from the FIX-HF-5 study of its OPTIMIZER System at the 58th Annual Scientific Session of the American College of Cardiology in Orlando, Florida.

Previous studies have demonstrated safety and efficacy of the OPTIMIZER System's cardiac contractility modulation (CCM) signals when applied for three months. The FIX-HF-5 study was designed to test the longer term effects in the largest randomized study to date.

The study met its primary safety endpoint, which was a noninferiority demonstration of the composite of all-cause mortality and all-cause hospitalizations. In terms of efficacy, the results showed that, compared to the control group, patients treated with CCM signals over the other group had significantly improved exercise tolerance as judged by an increase in peak oxygen update (p=0.02) and an improvement in quality of life as judged by a reduction in the Minnesota Living with Heart Failure score (p<0.0001). Although the results did not meet the study's overall primary efficacy endpoint demonstrating improvement in ventilatory anaerobic threshold, it was met in a subgroup of the patients.

"We are pleased to report these longer term data that add to the growing wealth of knowledge showing the potential of CCM as a therapy for heart failure patients with no other options," said Dr. William Abraham, professor of internal medicine and director of the Division of Cardiovascular Medicine, Ohio State University Medical Center.

In a subgroup representing the "less sick" half of the study population (NYHA Class III with ejection fraction 25% and above), the study found even greater improvements not only in peak VO2 (p=0.001) and quality of life (p=0.003), but also in the primary endpoint of vent
'/>"/>

SOURCE Impulse Dynamics (U.S.A.) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO
2. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
3. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
4. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
7. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
8. Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients
9. XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
10. Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions
11. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ON, Minn, Nov. 27 ACUO TECHNOLOGIE...nagement software, data migration tools and servic...Patent and Trademark Office has approved a patent ...hin a Computer Network." Acuo Technologies is plea...ellectual property. In general, the granted patent...
(Date:11/25/2009)...AND, Colo., Nov. 25 Hesk...er of advanced diagnostic and specialty products...ments with Roche Diagnostics Corporation for the s...bles for the veterinary market. ,, (Logo: ...LOGO ) ,, "Heska and Roche share the same passi...
(Date:11/25/2009)...v.25/PRNewswire/--BioTrendsResearchGroup,Inc.relea...t,thefirstinamulti-phasesyndicatedmarketresearchpr...lara,fromproductlaunchthroughthefirstsixmonthsofav...informationfrom75uniqueDermatologistsandqualitativ...nduseofStelara,obstaclestouse,typicalpatienttypes,...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 14938 1Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 14938 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 1Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 5Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 6Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 7Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 8Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 9Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 10QlikTech Wins Healthcare IT Innovation 26amp 3B 238482 3B Award 61914 1QlikTech Wins Healthcare IT Innovation 26amp 3B 238482 3B Award 61914 2QlikTech Wins Healthcare IT Innovation 26amp 3B 238482 3B Award 61914 3QlikTech Wins Healthcare IT Innovation 26amp 3B 238482 3B Award 61914 4
(Date:11/27/2009)...LY-SUR-SEINE, France, Nov. 27 Team...l cycling team dedicated to ethical sporting and d..., announced today that it will become Team Garmin-...al as a new sponsor of the team. Transitions Optic... eyewear, offering the most advanced photochromic ...
(Date:11/27/2009)....27/PRNewswire/-- Allrecipes.com , theworld,s#1fo...rs,withmorethan2.8millionvisitorsthedaybeforeThank...biggestfoodholidayoftheyear.TheaverageThanksgiving...centincreasefromlastyear,sfeast.AccordingtotheAllr...opularThanksgivingrecipe,acontrastfromlastyear,spo...
(Date:11/26/2009)...K, Nov. 27 With cold and flu seaso... good practices to control the spread of infection...e not only to keep ourselves healthy, but to avoid...Finerty, RN, MS, CIC (certified in infection-contr...cupational health at Hospital for Special Surgery ...
(Date:11/26/2009)...hrill when on an emotional rollercoaster, study fi...s) -- Call it the fear factor meets the jubilant s...rs -- especially those who root for the winning te...osely contested match and victory was in doubt, pr...hew on that this Thanksgiving weekend as you,re gl...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free na...az and Yasmin birth control pills who have suffere..., Stroke, Heart Attack or other related cardiac is...all toll free at 1-800-856-6405 or go to the firm&...ill out an online case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...o,s residents cross the Texas-Mexico border to Ciu...services, according to a study by researchers at T...Paso Regional campus. , Results from this study ...r purchase of health care and medications from a r...
...maged brain areas did not bring significant reduct...IDAY, Feb. 20 (HealthDay News) -- An experimental...significantly reduce disability in stroke patients...e University of California, San Diego used the Neu...
...eb. 20 Misonix, Inc. (Nasdaq: MSON ), a develop... technology, which in Europe is used for the ablat... conditions, has entered into a new, three year, e...he SonaStar(TM) Ultrasonic Surgical Aspirator and ...
...o destroy bad, not good, E. coli, , , FRID...for new drugs to fight the bacteria that cause man... U.S. researchers. , Two molecules called yersinia... two molecules -- called siderophores -- could he...
... BurrellesLuce Vice President Johna Burke, a p...ment, will be one of the expert panelists discussi...meeting of the National Capital Chapter of the Pub... prominent authority on media monitoring and measu...
...orld Health Organization has designated the Regens... world,s first WHO Collaborating Center for Medica... for the "design, application, and research of med...nnovative use of information technology within med...
Other Medicine News:Health News:Lack of insurance drives El Pasoans across the border for healthcare 2Health News:Laser Therapy Disappoints in Stroke Trial 2Health News:Misonix Announces New Distribution Agreement for Israel 2Health News:Misonix Announces New Distribution Agreement for Israel 3Health News:Finding May Lead to New Drugs for Urinary Infections 2Health News:BurrellesLuce VP Johna Burke Among Measurement Experts To Speak at Feb. 25 Meeting of PRSA's National Capital Chapter 2Health News:BurrellesLuce VP Johna Burke Among Measurement Experts To Speak at Feb. 25 Meeting of PRSA's National Capital Chapter 3Health News:Regenstrief Institute receives World Health Organization designation 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: